Remark(s)
|
CF is the most common life-limiting autosomal recessive disorder in Caucasian population. Patients may be homozygotes for a mutation or compound heterozygotes
most common mutation, DeltaF508 omits the phenylalanine residue at position 508 in the first nucleotide binding domain (NBD1) of CFTR; mutant protein is retained in the endoplasmic reticulum and degraded by the ubiquitin-proteasome system
mutant protein delta F508 fails to fold properly and is targeted for proteosomal degradation.;G551D, the second most common mutation, causes loss of function of the protein at the plasma membrane (PMID: 19837664))
mutation delta F508 results in disruption of the energetics of the protein fold, leading to efficient degradation of CFTR in the endoplasmic reticulum, but posible restoration of deltaF508 CFTR function in primary lung epithelial cells through HDACi-sensitive mechanisms (PMID: 19966789))
{Delta}F508 mutation in CFTR down regulates the antigen presentation pathway, impairs immune function in airway epithelial cells but may not increase inflammation (PMID: 20044437))
(deltaF508), the most prevalent mutation, causes a temperature-sensitive folding defect, and instability was attributed to unfolding and subsequent ubiquitination, internalization, and lysosomal degradation
loss of anion transport is key to airway epithelial dysfunction in CF (PMID: 21646513))
F508del mutation in accounts for most of Caucasian CF genotypes and results in dysfunctional chloride secretion in pulmonary epithelium, leading to a severe and chronic lung inflammation and bacterial infection
the F508del mutation in CFTR impacts trabecular bone mass by reducing bone formation (PMID:22449949))
SPNS2 transporter contributes to the accumulation of S1P in Cystic Fibrosis human bronchial epithelial cells (PMID: 34572307)) |